CW September 2004
Volume 13Issue Number 9 September 2004 ISSN 10593802 Improved Targeting for Suspicious Recurrence in Prostatectomy PatientsProstascint, an Indium-111-labeled monoclonal antibody that specifically binds to prostate-specific membrane antigen when used in conjunction with a computed tomography scan provides better information about targets for radiotherapy after surgery.
Go to Previous Page Go to Next Page Source & Additional Reading Journal of Nuclear Medicine, August 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW September 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
